A Season of Tributes
Tributes in 2006 honored four medical center leaders who have devoted a total of 80 years of service to Columbia: outgoing EVP and dean Gerald Fischbach, outgoing Mailman School of Public Health dean Allan Rosenfield, former medical center head and P&S dean Paul Marks, and longtime pathology chairman Michael Shelanski.
Allan Rosenfield, M.D.
Dr. Rosenfield, who has announced his plans to step down as dean of the Mailman School of Public Health after 20 years, was the guest of honor at two tribute events in 2006, the first at the Morningside campus in June, the second at the medical center campus in September. (More about his career and impact can be found in a profile in this issue.) Dr. Rosenfield, a 1959 graduate of P&S who joined the Columbia faculty in 1975, will remain on the Mailman faculty as a professor of public health and on the P&S faculty as professor of obstetrics and gynecology.
On the eve of a United Nations symposium on the fight against HIV and AIDS, Columbia President Lee Bollinger hosted a June 2006 gala to honor Dr. Rosenfield’s 40-year career in advancing the health and human rights of people worldwide through innovative programs in reproductive health, maternal mortality, and the treatment of HIV-infected adults and children. Tributes were given by then UN Secretary-General Kofi Annan; former president Bill Clinton; Richard Gere, founder of Healing the Divide and an active campaigner for AIDS awareness in India; and Phyllis Mailman, widow of Joseph L. Mailman, for whom the Mailman School of Public Health is named.
In September, the Mailman School hosted a celebration of Dr. Rosenfield’s 20 years as dean. More than 800 members of the Mailman “family” faculty, staff, students, and alumni and colleagues throughout Columbia attended the event in the National Track and Field Hall of Fame, known locally as the Armory. Speakers included Columbia President Lee Bollinger and Lee Goldman, the new Executive Vice President for Health and Biomedical Sciences and Dean of the Faculties of Health Sciences and Medicine. The Mailman School’s six department chairs and other faculty spoke. An alumnus who flew in from Geneva and current students also participated. Dr. Rosenfield’s son, Paul Rosenfield, an assistant clinical professor of psychiatry at P&S, delivered a moving tribute.
Dr. Rosenfield was given a book of more than 200 letters dedicated to him by former and current faculty, staff, students, and alumni. A hand-blown crystal globe of the world was presented to him with an inscription that says, “You Made A Difference In Our World.”
Paul Marks, M.D.
A day-long scientific symposium in September honored the contributions of Paul A. Marks, M.D., an internationally renowned cell biologist, physician-scientist, and academic leader. Speakers at the symposium, “Frontiers of Biomedical Research in the 21st Century: Celebrating Science in New York City,” saluted Dr. Marks, who spent more than a half-century at Columbia. Dr. Marks’ scientific career contributed toward defining the cellular and molecular mechanisms that cause the differentiation and transformation of normal blood cells into cancerous cells.
More than 800 people attended one or more sessions at the seminar, which featured talks by eight Nobel Prize winners and other eminent scientists.
Columbia participants included Richard Axel, M.D.; Columbia President Lee Bollinger; EVP and Dean Lee Goldman, M.D.; Arthur Bank, M.D.; Eric Kandel, M.D., James Rothman, Ph.D.; and Ronald Breslow, Ph.D. Other speakers were Cori Bargmann, Ph.D., Rockefeller University; Michael Brown, M.D., University of Texas Southwestern Medical Center; Joseph L. Goldstein, M.D., University of Texas Southwestern Medical Center; Paul Greengard, Ph.D., Rockefeller University; Mary-Claire King, Ph.D., University of Washington; Richard A. Lerner, M.D., Scripps Research Institute; Paul Nurse, Ph.D., Rockefeller University; Mark Ptashne, Ph.D., Memorial Sloan-Kettering Cancer Center; Robert Roeder, Ph.D., Rockefeller University; and Bengt Samuelsson, M.D., Karolinksa Institute, Stockholm.
Dr. Marks graduated from P&S in 1949 and completed residency training and a fellowship at Columbia. He returned to P&S in 1955 as instructor in medicine and researcher of mechanisms of protein synthesis in cells. As dean and vice president, starting in 1970, he is credited with reorganizing the administrative structure to create a modern team of professionally trained personnel. His efforts to expand external support for teaching and research made P&S one of the largest private academic centers for biomedical research in the country. In 1973, Dr. Marks gave up the dean’s title when the deanship and vice presidency were separated, but he continued as vice president for medical sciences, a new position, until 1980.
Dr. Marks developed the Department of Human Genetics at P&S and served as its first chairman. He also was director of the Cancer Research Center, which he and other faculty members organized in 1972. The cancer center became a prestigious National Cancer Institute-designated comprehensive cancer center shortly after its creation and has developed into today’s influential Herbert Irving Comprehensive Cancer Center. He is president emeritus of Memorial Sloan-Kettering Cancer Center, which he led from 1980 until retiring in 1999.
Michael Shelanski, M.D., Ph.D.
Dr. Shelanski’s 20 years as chairman of the Department of Pathology were saluted in a November event, “Neuronal Function and Degeneration: A Symposium to Honor Michael L. Shelanski, M.D., Ph.D.” Presentations were made by his former trainees, Dennis J. Selkoe, M.D., Harvard Medical School; Virginia M-Y Lee, Ph.D., MBA, University of Pennsylvania School of Medicine; Stephen Salton, M.D., Ph.D., Mount Sinai School of Medicine; Ronald K.H. Liem, Columbia University; and Rajiv R. Ratan, M.D., Ph.D., Weill Medical College of Cornell.
After serving on the faculty of the Albert Einstein College of Medicine, Harvard, and NYU, Dr. Shelanski joined P&S in 1987 as the Francis E. Delafield Professor and Chairman of Pathology. He is internationally known for his pioneering studies of the cytoskeleton, particularly the structure of the cytoskeleton of neurons. He has conducted important studies of the biological function of microtubules and neurofilaments, which hold potential significance in understanding the aging brain and nervous system and such neurological diseases as Alzheimer’s. He was elected to the prestigious Institute of Medicine in 1999.
He also directs the M.D./Ph.D. program at P&S and is co-director of the Taub Institute for Research on Alzheimer’s Disease and the Aging Brain. After attending Oberlin College, he received M.D. and Ph.D. degrees from the University of Chicago. Before joining P&S, he was professor and chairman of the Department of Pharmacology at NYU.
Gerald Fischbach, M.D.
In November, a symposium that saluted the leadership and career of Dr. Fischbach was titled, “From Basic Science to Public Policy: A Tribute to the Scientific and Academic Leadership of Gerald D. Fischbach, M.D.”
Dr. Fischbach, who was executive vice president of the medical center and P&S dean from February 2001 until June 2006, is former director of the National Institute of Neurological Disorders and Stroke of the NIH and former faculty member at Harvard and Washington University.
A neuroscientist by training, he is past president of the Society of Neuroscience. He is a member of the Institute of Medicine and the American Academy of Arts and Sciences, a Fellow of the American Association for the Advancement of Science, and a nonresident Fellow of the Salk Institute.
As a scientist, he has pioneered the use of nerve cell cultures to study the electrophysiology, morphology, and biochemistry of developing nerve-muscle and inter-neuronal synapses.
The symposium was hosted and moderated by Eric Kandel, M.D., University Professor, the Fred Kavli Professor, director of the Kavli Institute for Brain Sciences, and senior investigator, Howard Hughes Medical Institute; and Timothy A. Pedley, M.D., chairman of the Department of Neurology.
Presentations were given by Thomas M. Jessell, Ph.D., Columbia University; Charles F. Zorumski, M.D., Washington University; Roderick MacKinnon, M.D., Rockefeller University; Story Landis, Ph.D., National Institute of Neurological Disorders and Stroke; and Zach W. Hall, Ph.D., California Institute for Regenerative Medicine. David Hirsh, Ph.D., executive vice president for research, gave closing remarks on Dr. Fischbach’s leadership of academic medicine at Columbia.
Health Care in the Community: What Does it Mean?
P&S students try to answer the question at a pioneering conference
By Robin Eisner
The word community, derived from the Latin word communis, refers to that which is common, public, general, or shared by all or many. We all carry inside of us some idea of community, be it where we grew up or live now, or how we identify our race, religion, politics, socioeconomic status, or gender. That sense of being in a community often defines our sense of self.
When people come to see a doctor in an office, medical clinic, or hospital, they often are venturing from one kind of community into another. Understanding the role community plays in defining the patient and physician relationship and developing ways to improve partnerships between medicine and community were some of the goals of a medical center conference, “The Community Pulse,” organized by a group of P&S students.
The one-day conference in September 2006 brought together approximately 65 participants students and faculty from the medical, dental, nursing, and public health schools and other schools of Columbia University and students and professionals from elsewhere, including New York University and the World Health Organization to discuss community and health.
“Although as students, many of us came to P&S because of its location in New York City and the Washington Heights community, and in our course work we address cultural competency and sensitivity to groups who are different than ourselves, some of us wanted to delve deeper into the issue of community,” explains Lauren Taggart Wasson’09, one of the conference organizers.
“We wanted to begin a dialogue exploring how we, as medical professionals, can work with communities rather than dictate the terms of the relationship, as might have been done in the past. We wanted to figure out how to determine what kind of services members of the community really need beyond what we as clinicians or researchers think they need. We wanted to explore the relationship between global issues in medicine and their impacts locally. Ultimately, we are hoping to become members of communities working together as partners in health care.”
To get the conversation started, Olveen Carrasquillo, M.D., principal investigator of the Columbia Center for the Health of Urban Minorities, director of the Community Liaison Core of the Columbia Center for the Active Life of Minority Elders, and director of the General Medicine Fellowship Program, provided the opening salvo, describing his experiences working at CUMC in the largely Dominican neighborhood of Washington Heights. While pointing out some rough spots during the years, he acknowledged the relationship between the medical center and the community had improved significantly.
The break-out sessions addressed partnerships between the medical center and the community, ethical considerations for community-based research, the training of physicians to be community members and leaders, the intersection of the community and family medicine, the local and global connection in health care, and health disparities among minorities.
The sharing of goals, decision making, funding, and leadership is key to the success of joint health-care
projects, speakers at the partnership session agreed. Milagros Batista, co-founder and senior program director of Alianza Dominicana, a nonprofit development organization that partners with youth, families, and public and private institutions to revitalize economically distressed neighborhoods, noted the combined effort by the New York Society for the Prevention of Cruelty to Children, the Department of Pediatrics, New York-Presbyterian Hospital, and her organization, founded in 1987, in establishing and continuing Best Beginnings, a home visitation service started in 1994 for pregnant and parenting women whose children may be at risk for child abuse.
Likewise, Benjamin Ortiz, M.D., associate professor of clinical pediatrics, described the cooperation among more than 10 entities in creating the Harlem Children’s Zone Asthma Initiative, a community, home-based intervention designed to educate and provide services for families and children living with asthma. The entities included Harlem Hospital Center, Columbia’s Graduate School of Architecture (which helped map the relationship between traffic patterns and health), and the city’s Board of Education (because you cannot work in the schools without board permission).
At the local and international health session, led by Kathleen Klink, M.D., director of the Center for Family Medicine, and Richard Garfield, DrPH, R.N., the Henrik H. Bendixen Professor of Clinical Nursing at the School of Nursing, opportunities for those who want to work internationally were discussed. “Just do it,” was the advice both gave. Two physicians and a translator from Dr. Klink’s exchange program with China were in attendance to gain knowledge about America’s approach to primary care. Dr. Garfield, who helped develop a nurse-run primary care practice at the National Autonomous University of Santo Domingo in the Dominican Republic, also discussed the fluidity with which Dominicans move back and forth between the United States and DR, raising issues about continuity of health care.
At the end of the day, keynote speaker Shaffiq Essajee, M.D., reminded those assembled that we live in a global community, and actions abroad can have consequences locally and vice versa. Dr. Essajee, senior pediatric adviser to the Clinton Foundation HIV/AIDS initiative and associate director of NYU’s International HIV program, described how he helped create the first free pediatric HIV clinic in Kenya, supported locally and from abroad. Lee Goldman, M.D., executive vice president and dean, introduced Dr. Essajee and noted CUMC’s commitment to the health of “people right around the corner and in the farthest corner of the world.”
Other members of the conference committee were Jake Doll’09, Erin Ferenchick’08, Emily Hurstak’09, Stephanie Long’09, and Mark Manseau’08.
|New Center to Coordinate Human Genetics Initiatives
A new Center for Human Genetics will promote and coordinate efforts in human genetics at CUMC and provide information on human genetics resources, services, programs, and investigators.
The center will foster interactions among Columbia’s many genetics-related centers and programs, including the Columbia Genome Center, the Institute for Cancer Genetics, the Center for Computational Biology and Bioinformatics, the Gertrude H. Sergievsky Center, the medical genetics residency, the American Board of Medical Genetics fellowships, and departmental programs.
The new center will help develop human genetics education programs and expand clinical genetics and diagnostic testing and will provide a centralized resource for genetics technologies, including the Human Genetics Resources Core for DNA banking and available sequencing and genotyping resources on the campus.
Angela M. Christiano, Ph.D., the Richard & Mildred Rhodebeck Professor of Dermatology and of Genetics and Development, directs the new center. She will work with an executive committee made up of Richard Mayeux, M.D., the Gertrude H. Sergievsky Professor of Neurology, Psychiatry and Epidemiology; Rudolph Leibel, M.D., professor of pediatrics and medicine; Qais Al-Awqati, M.D., the Robert F. Loeb Professor of Medicine and professor of physiology and cellular biophysics; Michael Shelanski, M.D., Ph.D., the Delafield Professor and Chairman of Pathology; and Gerard Karsenty, M.D., chairman of genetics and devel opment.
Center members include more than 40 faculty from multiple and diverse departments and institutes.
New Multimillion Dollar Grant Ushers in New Era in Clinical Science
Columbia University Medical Center is one of the first 12 recipients of a competitive Clinical and Translational Science Award (CTSA) intended to transform how clinical and translational research is conducted throughout American academic medicine. The centers, established with NIH funding, will form a national consortium focused on innovation, the streamlining and expediting of clinical research, and delivery of new treatments to patients.
The 12 recipients were among 32 institutions who applied for the grants, announced in October 2006. NIH hopes to have as many as 60 centers linked in a national consortium by 2012. The consortium, in focusing on clinical and translational science, is envisioned to accelerate translation of new discoveries into clinical applications.
“The development of this consortium represents the first systematic change in our approach to clinical research in 50 years,” says NIH Director Elias A. Zerhouni, M.D. “Working together, these sites will serve as discovery engines that will improve medical care by applying new scientific advances to real world practice. We expect to see new approaches reach underserved populations, local community organizations, and health care providers to ensure that medical advances are reaching the people who need them.”
The award will provide $54 million over five years to Columbia, allowing the establishment of an Irving Institute for Clinical and Translational Research. It will expand core resources available to clinical researchers, such as Columbia’s already distinctive biomedical informatics support and biostatistical analysis. The Irving Institute would serve as the intellectual home for the next generation of clinical and translational investigators across all schools at CUMC, with the support of New York-Presbyterian Hospital.
The proposed Irving Institute will benefit from support from the Herbert Irving Endowment, established
by Herbert and Florence Irving. It would expand and reconstitute the NIH-funded General Clinical Research Center now called the Irving Center for Clinical Research which has been a well-established and productive center of clinical research at Columbia for 35 years. The CTSA will provide a wide range of support for Columbia research, including providing inpatient and outpatient facilities, core laboratory support, statistical analysis, and informatics and nutrition support.
“We expect this investment to allow exponential growth in clinical research here at Columbia University Medical Center,” said Henry Ginsberg, M.D., director of
the Irving Center and the principal investigator on the CTSA. “Columbia’s current clinical research center provides resource support for about 25 percent of clinical research across our campus, but with the expanded resources of the new CTSA, we hope to extend involvement to 75 percent.”
The grant will enable a number of new educational programs to prepare young researchers and clinicians for a successful career in translational research. These programs will include naming junior faculty as Irving Fellows to work with senior faculty in developing novel approaches for more collaborative interdisciplinary clinical and translational research; supporting P&S graduate students interested in clinical research and clinical researchers interested in doing rotations in basic sciences; and a new Ph.D. program in clinical research, which will be one of only a few programs in the nation.
The CTSA funding will support construction of physical spaces needed for new research integration initiatives. Columbia will add 35,000 square feet to the space now dedicated to clinical/translational research programs to accommodate additional space requirements for outpatient research, an educational center where master’s and Ph.D. students can better collaborate on research, and a new center for community-based clinical and translational research near the CUMC campus.
The other 11 recipients of the first round of grants: Duke University Medical Center, Mayo Clinic College of Medicine, Oregon Health and Science University, Rockefeller University, University of California, Davis, University of California, San Francisco, University of Pennsylvania School of Medicine/Children’s Hospital of Philadelphia, University of Pittsburgh, University of Rochester School of Medicine and Dentistry, University of Texas Health Science Center at Houston, and Yale University School of Medicine.
|Relay for Life
Columbia’s 2007 Relay For Life is committed to fighting cancer. For the fourth year, Columbia is sponsoring the 15-hour event to benefit the American Cancer Society. Relay for Life will be Saturday, March 31, starting at noon. The event will run til 3 a.m. the next day. Participants are asked to form teams of 10 to 15 members. Each team member will take a turn walking a track set up on Low Plaza on the Morningside campus while other team members enjoy entertainment, food, games, and prizes. In the past three Relay for Life events, Columbia’s 1,600 participants raised more than $234,000 for the American Cancer Society.
Go to www.acsevents.org/relay/ny/columbia to create a team or to join an existing team. More information is available from Samara Rudolph (firstname.lastname@example.org) or Emily Sikora (email@example.com).
New Administrators Named to Leadership Roles
A graduate of the Mailman School of Public Health and a Mailman administrator have been named to new roles in the central administration of Columbia University Medical Center. Thomas Jackiewicz and Joanne Quan began their roles as chief operating office and chief financial officer, respectively, in late 2006.
Tom Jackiewicz, who received his master of public health degree from Mailman, has been associate vice chancellor for finance and administration at UC San Diego Health Sciences, where he was a member of the senior health sciences management team. He will work directly with Lee Goldman, M.D., executive vice president and dean of the faculties of health sciences and medicine, in managing clinical, research, and educational initiatives for the medical center.
Mr. Jackiewicz managed a significant expansion during his tenure at UCSD, including the planning and coordination of two major new structures a biomedical research building and a cancer center. He was also part of the executive management team that developed a new model for the UCSD medical center to consolidate inpatient activity at the La Jolla campus. He held senior management positions at Stanford, Oregon Health Sciences, and the University of Pennsylvania before joining UCSD in 2001. He is chair-elect of the Group on Business Affairs of the Association of American Medical Colleges.
Joanne Quan has been vice dean for finance and administration of the Mailman School of Public Health since early 2004. While a new dean for the Mailman School is recruited, Ms. Quan will continue to provide financial and administrative leadership at the school. In her new role at CUMC, she will play a key leadership role in financial operations, reporting, and planning.
At Mailman she led an effort that resulted in a three-year action plan to restructure and better manage the school’s finances. Now in its second year, this program is delivering successful results.
Earlier in her career, Ms. Quan was vice president for finance at New York University Medical Center and deputy director for health care financing at the New York State Department of Health. She has a bachelor’s degree in mathematics from Stanford and a master’s in operations research from Yale.
Four Elected to Institute of Medicine
Faculty from Columbia’s nursing, public health, and medical schools were elected to membership in the Institute of Medicine, one of the highest honors in the fields of medicine and health.
|Clockwise from top left: Suzanne Bakken, Betty Diamond,
Stephen Goff, Sherry Glied
The four Suzanne Bakken, Betty Diamond, Sherry Glied, and Stephen Goff were among the 70 new IOM members and foreign associates announced in October 2006. They were chosen through a highly selective process that recognizes individuals who have made significant contributions to advancing the medical science, health care, and public health fields.
Suzanne Bakken, R.N., F.A.A.N., D.N.Sc., is Alumni Professor of Nursing in the School of Nursing and professor of biomedical informatics in P&S and the School of Nursing. She researches informatics and evidence-based nursing practice, including the use of web-based approaches for interactive health communication for underserved populations.
Betty A. Diamond, M.D., was the Dorothy L. and Daniel H. Silberberg Professor of Medicine, professor of microbiology, and chief of rheumatology for the past few years until resigning this year to accept a position elsewhere. Her research and clinical expertise in autoimmune disorders, such as lupus, have earned her a national reputation in the field.
Sherry A. Glied, Ph.D., is professor and chair of the Department of Health Policy and Management at the Mailman School of Public Health. Her research focuses on health policy reform, the financing of health-care services, and mental health care policy. She served as a senior economist for health-care and labor market policy on the President’s Council of Economic Advisers under two U.S. presidents.
Stephen P. Goff, Ph.D., the Higgins Professor of Biochemistry and Molecular Biophysics, professor of microbiology, and investigator in the Howard Hughes Medical Institute at P&S, studies the replication of retroviruses, the cellular gene products that interact with these viruses, and the signal transduction pathways that are activated in retrovirus-induced tumors. He was elected to the prestigious National Academy of Sciences early in 2006.
The Institute of Medicine is part of the National Academies, which also includes the National Academy of Sciences, the National Academy of Engineering, and National Research Council. Also in 2006, Nancy S. Wexler, Ph.D., the Higgins Professor of Neuropsychology (in psychiatry, neurology, and the Center for Neurobiology and Behavior), was elected to a term on the IOM Council. She will serve from 2007 through 2009. Another Columbia faculty member, Edward H. Shortliffe, M.D., Ph.D., the Rolf H. Scholdager Professor and Chairman of the Department of Biomedical Informatics at P&S, is also a member of the IOM Council.
|News in Brief . . . The first Katz Prizes in Cardiovascular Research were awarded to an accomplished cardiologist at Harvard and a promising young molecular cardiologist at Columbia. The life’s work of Eugene Braunwald, M.D., the Distinguished Hersey Professor of Medicine at Harvard Medical School and chairman of the Thrombolysis In Myocardial Infarction study group at the Brigham and Women’s Hospital, was recognized by the inaugural Lewis Katz Visiting Professorship in Cardiovascular Research. Geoffrey S. Pitt, M.D., Ph.D., the Esther Aboodi Assistant Professor of Medicine and assistant professor of pharmacology in the Center for Molecular Cardiology at Columbia, was awarded the Lewis Katz Cardiovascular Research Prize for a Young Investigator, which recognizes a junior faculty member with great promise for contribution to the study of cardiovascular disease. The Katz Prizes were created at Columbia through the generosity of entrepreneur and philanthropist Lewis Katz to recognize excellence in cardiovascular research and education. ... Six medical center faculty were elected to fellowship in the American Association for the Advancement of Science, one of the world’s oldest, largest, and most prestigious scientific societies. The newest Columbia Fellows selected by the greater AAAS membership from among its own ranks are Lloyd A. Greene, Ph.D., professor of pathology in the Center for Neurobiology and Behavior; Barry Honig, Ph.D., professor of biochemistry and molecular biophysics; Thomas M. Jessell, Ph.D., the Claire Tow Professor of Motor Neuron Disorders in Biochemistry and Molecular Biophysics in the Center for Neurobiology and Behavior; Howard B. Lieberman, Ph.D., professor of radiation oncology; Carol A. Mason, Ph.D., professor of pathology in the Center for Neurobiology and Behavior; and Constance Nathanson, Ph.D., professor of clinical sociomedical sciences in the Mailman School of Public Health. ... The American Society of Hematology, the world’s largest professional society of blood specialists, honored Columbia’s Riccardo Dalla-Favera, M.D., with one of its two highest honors at the society’s annual meeting in December 2006. He received the William Dameshek Prize, awarded to an individual who has made an outstanding and recent contribution to hematology. Dr. Dalla-Favera, the Uris Professor of Pathology and Genetics and Development and director of the Herbert Irving Comprehensive Cancer Center, was one of the first to illustrate specific genetic abnormalities leading to the development of cancer. In particular, his identification of the MYC and BCL6 oncogenes and their role in B-cell lymphoma provided critical advances in the understanding of the pathogenesis of this disease and may lead to new targets for diagnosis and therapy. … Edward H. Shortliffe, M.D., Ph.D., received the 2006 Morris F. Collen Award of Excellence from the American College of Medical Informatics. The prestigious award is presented to an individual whose personal commitment and dedication to medical informatics has made a lasting impression on the field. Dr. Shortliffe is the Rolf Scholdager Professor and Chairman of Biomedical Informatics and professor of medicine at P&S, deputy vice president at CUMC, and senior associate dean for strategic information resources. ... Suzanne Bakken, RN, DNSc , received the American Medical Informatics Association’s 2006 Virginia K. Saba Informatics Award, which recognizes an individual with exemplary principles and practices and a substantial record of contribution to the field of nursing informatics. Dr. Bakken is the Alumni Professor of Nursing in the School of Nursing and professor of biomedical informatics at P&S. ... Richard Polin, M.D., professor of pediatrics and director of the neonatology division, has received the annual Neonatal Education Award in Perinatal Pediatrics from the American Academy of Pediatrics. The award recognizes an individual who has made outstanding and enduring contributions to excellence in neonatal and perinatal medicine. ... The 2006 Louisa Gross Horwitz Prize was awarded to structural biologist Roger D. Kornberg, Ph.D., the Winzer Professor in Medicine at the Stanford School of Medicine and the 2006 winner of the Nobel Prize in Chemistry. The Horwitz Prize was established by Columbia to recognize outstanding contributions to basic research in the fields of biology and biochemistry. ... A Columbia scientist is among six scientists working toward the development of novel therapies for brain diseases who will receive 2007 Neuroscience of Brain Disorders Awards from the McKnight Endowment Fund for Neuroscience. Lorna Role, Ph.D., professor of anatomy and cell biology, received a grant for a project in which she will examine whether nicotine-based therapeutics might mitigate the severity of some schizophrenic symptoms, such as memory deficits and poor attention span. The goal of the research is to identify molecular targets for potential therapies for schizophrenia and other brain disorders. ... Columbia has executed an exclusive license agreement for a next generation DNA sequencing technology to Intelligent Bio-Systems. The innovative DNA-sequencing technology was invented by Jingyue Ju, Ph.D., professor of chemical engineering and head of DNA sequencing and chemical biology at the Judith P. Sulzberger, M.D. Columbia Genome Center. Columbia, in collaboration with the Waltham, Mass.,-based Intelligent Bio-Systems, is one of only two recipients of the Near-Term Technology Development for Genome Sequencing grants from the National Human Genome Research Institute. The $425,000 grant is for the development of a “High-Throughput DNA Sequencing by Synthesis Platform.” ... The world’s largest donor-supported philanthropy, NARSAD: The Mental Health Research Association, has honored three P&S faculty: Jeffrey A. Lieberman, M.D., chairman of psychiatry; David Shaffer, M.D., chief of child and adolescent psychiatry; and, Lorna Role, Ph.D., professor of anatomy and cell biology. Dr. Lieberman, who also is director of the New York State Psychiatric Institute, was awarded the Lieber Prize for Schizophrenia Research, which honors a scientist who has made distinguished contributions to the understanding of schizophrenia. At Columbia, Dr. Lieberman holds the Lieber Chair and directs the Lieber Center for Schizophrenia Research. Dr. Shaffer was one of two scientists awarded the Ruane Prize for Childhood Psychiatric Disorders; his award recognized his research on teen suicide and its prevention. Dr. Role received the Sidney R. Baer Jr. Prize as a psychiatric investigator who is conducting particularly promising research.